HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oreal Litigation Win Is Good News For Marketers Of Pump-Dispensed Cosmetics

Executive Summary

Even if plaintiffs’ allegations are true and significant amounts of L'Oreal Paris and Maybelline pump-dispensed liquid makeup cannot be accessed by consumers due to the company's packaging design, plaintiffs’ deception claims still are preempted by federal statutes, a US district judge says, dismissing the proposed class action in New York’s Southern District.

You may also be interested in...



L’Oreal Makes Consumers Chumps With Its Liquid Cosmetic Pumps – Class Action Complaint

Plaintiffs in New York’s Southern District say a packaging defect strands product inside L’Oreal Paris and Maybelline liquid cosmetic bottles, causing consumers to lose up to $7 on every purchase.

Blistex Class Action Alleging Packaging Deception Comes Up Dry

If cosmetic packaging is deceptive because users allegedly have to work "extra hard" to wring out the last drops, "toothpaste tubes everywhere" would be deemed deceptive, Blistex argued in its motion to dismiss a proposed class action in Illinois district court. The case was dismissed in its entirety July 5.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel